Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
ZUG, Switzerland, April 10, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bra...
Source: businessinsider.com
David Nassif News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Nassif. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Nassif Today - Breaking & Trending Today
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrollingEnd-of-Phase 2 meeting...
Source: businessinsider.com
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
PARSIPPANY, N.J., Feb. 02, 2024 -- Sio Gene Therapies, Inc. today announced that it expects to file a certificate of dissolution with the Secretary of State of the State of Delaware, as...
Source: marketscreener.com
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
14.02.2023 - – Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively – Operating Cash Outflows for the Nine Months Ended December 31, 2022 decreased by $23.8 million or 56% versus the prior year period – $46.1 million of cash and cash ...
Source: wallstreet-online.de